BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/9/2026 9:23:56 AM | Browse: 0 | Download: 0
 |
Received |
|
2025-12-11 02:06 |
|
Peer-Review Started |
|
2025-12-11 02:06 |
|
First Decision by Editorial Office Director |
|
2025-12-26 09:52 |
|
Return for Revision |
|
2025-12-26 09:52 |
|
Revised |
|
2026-01-05 13:24 |
|
Publication Fee Transferred |
|
2026-01-08 08:13 |
|
Second Decision by Editor |
|
2026-01-27 02:37 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-01-27 07:36 |
|
Articles in Press |
|
2026-01-27 07:36 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-04-24 09:35 |
|
Publish the Manuscript Online |
|
2026-06-09 09:23 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Prognostic significance of baseline C-reactive protein/albumin ratio for long-term outcomes in advanced gastric cancer under immunochemotherapy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shuai Mei, Mei-Ling Ye, Qiu-Lin Hao, Geng-Chen Li, Zhi-Yuan Yao and Hai-Yan Wang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Hai-Yan Wang, Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, No. 99 Huaihai West Road, Quanshan District, Xuzhou 221000, Jiangsu Province, China. xzhaiyan68@163.com |
| Key Words |
Gastric cancer; C-reactive protein/albumin ratio; Programmed death-1 inhibitor; Predictive model; Efficacy; Safety |
| Core Tip |
The baseline C-reactive protein/albumin ratio (CAR) is a significant independent prognostic factor for advanced gastric cancer patients receiving combination immunotherapy and chemotherapy, with lower CAR levels associated with improved progression-free survival, overall survival, and higher objective response and disease control rates. By incorporating both inflammatory and nutritional status, the CAR index provides a more comprehensive evaluation of the immune microenvironment compared to traditional single inflammatory biomarkers. The CAR-integrated nomogram shows strong predictive accuracy, guiding personalized immunotherapy strategies. However, prospective, multi-center studies are needed to validate and refine its clinical applicability. |
| Publish Date |
2026-06-09 09:23 |
| Citation |
Mei S, Ye ML, Hao QL, Li GC, Yao ZY, Wang HY. Prognostic significance of baseline C-reactive protein/albumin ratio for long-term outcomes in advanced gastric cancer under immunochemotherapy. World J Gastrointest Oncol 2026; 18(6): 117582
|
| URL |
https://www.wjgnet.com/1948-5204/full/v18/i6/117582.htm |
| DOI |
https://doi.org/10.4251/wjgo.v18.i6.117582 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
